Degarelix: a gonadotropin-releasing hormone antagonist for the management of prostate cancer

Clinical Therapeutics
Michael Steinberg

Abstract

Prostate cancer is the most commonly diagnosed cancer among men. Treatment can include surgery, radiation, chemotherapy, or hormonal manipulation. Gonadotropin-releasing hormone (GnRH) analogues are used to manage prostate cancer by desensitizing the stimulus to synthesize and release gonadotropins, such as luteinizing hormone (LH), which stimulate the synthesis and release of androgens, in turn stimulating the growth of prostate cancer cells. Although effective, these agents have limitations, such as a flare-up of cancer symptoms within the first 2 weeks of starting the drug. This article reviews the pharmacology, pharmacokinetic and pharmacodynamic characteristics, and clinical data available on the newly approved drug degarelix for use in treating prostate cancer. A search of the medical literature was performed in January 2009 with the databases MEDLINE and EMBASE (1950-present) and International Pharmaceutical Abstracts (1970-November 2008) using the terms degarelix and FE200486; follow-up searches using the same strategy were conducted in May 2009 and August 2009. Additional sources were identified by scanning available references and online journals and textbooks. GnRH antagonists, such as degarelix, offer clinicians ano...Continue Reading

References

Feb 27, 1992·The New England Journal of Medicine·J E Griffin
Dec 1, 1982·American Journal of Clinical Oncology·M M OkenP P Carbone
Mar 22, 2002·The Journal of Pharmacology and Experimental Therapeutics·Pierre BroquaJean-Louis Junien
May 14, 2004·Pharmaceutical Research·Christoffer W TornøeE Niclas Jonsson
Jun 16, 2004·European Journal of Obstetrics, Gynecology, and Reproductive Biology·L Dal PratoC Flamigni
Sep 13, 2006·Journal of Pharmacokinetics and Pharmacodynamics·Pravin R JadhavJogarao V S Gobburu
Nov 21, 2007·Sleep Medicine·Mark S Scher

❮ Previous
Next ❯

Citations

Jan 11, 2012·Asian Journal of Andrology·Roisin M ConnollyEmmanuel S Antonarakis
Aug 8, 2013·JAAPA : Official Journal of the American Academy of Physician Assistants·Emily PatrickClint C Blankenship
Jul 19, 2013·Molecular Cancer Therapeutics·Sarah A LoddickA Nigel Brooks
Sep 10, 2011·Therapeutic Advances in Urology·Laurent Boccon-GibodBo-Eric Persson
Feb 2, 2013·Therapeutic Advances in Urology·Neal D Shore
Oct 30, 2015·Expert Opinion on Drug Metabolism & Toxicology·Laurence Klotz
Nov 5, 2014·Expert Opinion on Drug Discovery·Richard C LauerWadih Arap
Jul 27, 2015·Cancer Treatment Reviews·Galina KhemlinaRazelle Kurzrock
May 30, 2012·American Journal of Hematology·Martin H Steinberg, Paola Sebastiani
Mar 23, 2012·International Journal of Urology : Official Journal of the Japanese Urological Association·Damian GrucaUlf Tunn
Jun 1, 2010·American Journal of Hematology·Martin H SteinbergUNKNOWN Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia and MSH Patients' Follow-Up
Jun 25, 2015·British Journal of Haematology·Martin H Steinberg, Griffin P Rodgers
May 29, 2015·British Journal of Haematology·Amy SobotaMartin Steinberg
Jun 17, 2016·Molecular & Cellular Oncology·Antonella SistiguIlio Vitale
Nov 6, 2018·Current Drug Targets·Surovi SaikiaRajeev Sarmah
Apr 24, 2019·Journal of Investigative Medicine High Impact Case Reports·Richard SantenAzeez Farooki
Jun 16, 2019·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yuu MoriyaLeslie Z Benet
Jul 11, 2012·Endocrine Reviews·Patrizia LimontaRoberta M Moretti
Sep 14, 2018·Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians·Indunil N PathiranaHiromichi Tamada
Jun 5, 2020·Nature Reviews. Drug Discovery·Anthony P DavenportJanet J Maguire
Aug 3, 2016·The Journal of Steroid Biochemistry and Molecular Biology·Senthilmurugan RamalingamVincent C O Njar
Jul 17, 2019·Current Medicinal Chemistry·Haralambos TzoupisTheodore Tselios
Jul 25, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Giulia MazzoccantiFrancesco Gasparrini
Feb 16, 2019·Journal of the American Chemical Society·Alexander A VinogradovHiroaki Suga

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.